Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| EB Ecovia Bio develops biopolymer ingredients. | Undisclosed | Series B | Biotech | United States | Investors | |
| IM Develops AI-driven drug discovery and oncology treatments | $5M | StrategicUndisclosed | Biotech | United States | Investors | |
| B Develops AI infrastructure to improve clinical trial design and execution | $52M | Series A | Biotech, Healthtech | Spain | Investors | |
| E EpikastCompany profile Provides technology-enabled commercial and clinical services for biopharmaceutical industry Provides technology-enabled commercial and clinical services for biopharmaceutical industry | Undisclosed | Undisclosed | Biotech | United States | Investors | |
| TB Twogee BiotechCompany profile Develops customised enzyme solutions for converting biomass into sustainable raw materials Develops customised enzyme solutions for converting biomass into sustainable raw materials | €2.2M | Seed | Biotech, Climate tech | Germany | Investors | |
| TT Develops treatments to rejuvenate vision in the aging eye | $235M | Series B | Biotech | United States | Investors | |
| PC PranaX CorporationCompany profile Develops exosome-based technologies for regenerative biologics and wellness Develops exosome-based technologies for regenerative biologics and wellness | $17M | Series A | Biotech | United States | Investors Undisclosed | |
| A Builds AI-ready lab automation platforms for life sciences | $45M | Series CSeries C+ | Biotech, Industrial tech | United Kingdom | Investors | |
| P PrenosisCompany profile Develops integrated diagnostics and therapeutics for critical care conditions Develops integrated diagnostics and therapeutics for critical care conditions | $20M | Series A | Biotech | United States | Investors | |
| ET Elysium TherapeuticsCompany profile Develops treatments to prevent and reverse overdoses caused by synthetic opioids Develops treatments to prevent and reverse overdoses caused by synthetic opioids | $7.5M | SAFEUndisclosed | Biotech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →